Nanolyze provides new ultra-sensitive technology for analyzing nanoparticle uptake and release of substances. A necessary step for making future medicine more precise and efficient. Nanolyze is a research startup and our first line of products will be on the market in 2021. Our focus is both labs with high throughput requiring efficient automatized processes, and labs with fewer experiments, but need for low investment cost. Our system is scalable with the same unique capabilities for all setups. By putting the right pieces together, we will provide the optimal solution for industrial applications with high throughput as well as fundamental research applications with few measurements with detailed and precise output.
| Website | https://nanolyze.se/ |
| Employees | 4 (1 on RocketReach) |
| Founded | 2020 |
| Industry | Research |
| Keywords | Nanomedicine, Nanoparticle Analysis, Nanoparticle Characterization, Nanotechnology Research, Drug Delivery Systems, Efficient Drug Delivery, Pharmaceutical Research, Pharmaceutical Technology, Advanced Materials, Biomedical Engineering, Material Science, Biosensors, In-Vitro Diagnostics, Diagnostic Tools |
| Competitors | Henkel, BASF, 3M, Evonik, 陶氏化学(中国)投资有限公司, SABIC, Solvay, DSM, Kraton Polymers Research B.V. +40 more (view full list) |
Looking for a particular Nanolyze employee's phone or email?
Gaurav Goyal is the CEO of Nanolyze.
1 people are employed at Nanolyze.